Skip to Main content Skip to Navigation
Journal articles

Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: Additional analyses from the phase III RESORCE trial

Richard Finn Philippe Merle Alessandro Granito Yi-Hsiang Huang György Bodoky Marc Pracht 1 Osamu Yokosuka Olivier Rosmorduc 2 René Gerolami 3, 4 Chiara Caparello Roniel Cabrera Charissa Chang 5 Weijing Sun Marie-Aude Leberre Annette Baumhauer Gerold Meinhardt Jordi Bruix 
1 CRLCC - CRLCC Eugène Marquis
2 UPMC - Faculté de Médecine - Département d'Enseignement et de Recherche en Médecine Générale
3 Service d'hépato-gastro-entérologie [Hôpital de la Timone -APHM]
4 MEPHI - Microbes évolution phylogénie et infections
5 MSSM - Icahn School of Medicine at Mount Sinai [New York]
Document type :
Journal articles
Complete list of metadata
https://hal-amu.archives-ouvertes.fr/hal-02471037
Contributor : Isabelle COMBE Connect in order to contact the contributor
Submitted on : Friday, February 7, 2020 - 4:55:21 PM
Last modification on : Tuesday, January 25, 2022 - 4:28:02 PM

Identifiers

Collections

CNRS | UNIV-AMU | FNCLCC | MARQUIS | SORBONNE-UNIVERSITE | SU-MEDECINE

Citation

Richard Finn, Philippe Merle, Alessandro Granito, Yi-Hsiang Huang, György Bodoky, et al.. Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: Additional analyses from the phase III RESORCE trial. Journal of Hepatology, Elsevier, 2018, 69 (2), pp.353-358. ⟨10.1016/j.jhep.2018.04.010⟩. ⟨hal-02471037⟩

Export

BibTeX TEI DC DCterms EndNote Datacite

Share

Metrics

Record views

31